3652 results for «238»

Filter By

3652 results

CTO-PCI

07 Oct 2022 – From AICT-AsiaPCR 2022

Consider a 53-year-old man with a strong family history of MI, a history of exertion angina with cycling and dyslipidemia, or a 76-year-old male patient with hypertension, type 2 diabetes, previous CABG (2017), cholecystectomy (2018), left carotid endarterectomy (2018), left leg intervention (2018), and mild aortic...

CTO-PCI

Complex PCI with left ventricular support - Session with LIVE case

07 Oct 2022 – From AICT-AsiaPCR 2022

Look at this case of a 73-year-old man, heavy smoker, with hypertension, type 2 DM, and hyperlipidemia, who recently suffered class III effort-related angina and non-ST elevation MI, who presented with a totally occluded RCA, ulcerated LM, occluded LAD, and stenotic LCx, and study LIVE a complex PCI...

Complex PCI with left ventricular support

Surgical turndowns interventions and outcomes

07 Oct 2022 – From AICT-AsiaPCR 2022

Through this AICT AsiaPCR 2022 session, view a variety of case presentations and hear your peers discuss them to learn how to successfully manage high-risk PCI procedures.

Surgical turndowns interventions and outcomes

How to avoid and manage complications - Rupture and perforation

In this case-based discussion, learn with experts how to avoid major complications during PCI such as distal vessel perforation and mid vessel rupture, and through algorithms, how to manage them in case they occur.

Complications - Rupture and perforation

Tips, tricks and complications

08 Oct 2022 – From AICT-AsiaPCR 2022

Through 4 case examples, this discussion with experts will help you understand management strategies and problem solving for common and rare interventional complications. 

Tips, tricks and complications

How to deal with calcified coronaries

08 Oct 2022 – From AICT-AsiaPCR 2022

In this session, learn with experts about practical decisional algorithms to select the most appropriate tool in function of calcification severity and extension, and discover the contemporary tools and techniques for optimal plaque modification.

How to deal with calcified coronaries

AICT-AsiaPCR 2022's best clinical case and best abstract Awards

08 Oct 2022 – From AICT-AsiaPCR 2022

Percutaneous closure of a bleeding mycotic coronary artery aneurysm, superior vena cava aneurysm closed with an atrial septal defect device… Discover the best clinical cases and abstracts which were presented during AICT-AsiaPCR 2022.

Best clinical case and best abstract Awards

AICT-AsiaPCR 2022 Closing Ceremony

08 Oct 2022 – From AICT-AsiaPCR 2022

In this Closing Ceremony, Ashok Seth thanks all participants, Programme Committee Members, Faculty members and presenters, LIVE operating teams and Industry Partners for being part of this fantastic online and onsite edition of AICT-AsiaPCR 2022, while he highlights the key moments of the course.

AICT-AsiaPCR 2022 Closing Ceremony

Impact of intravascular imaging guidance on percutaneous coronary intervention of severely calcified lesions: The ECLIPSE trial

29 Mar 2025

Aaysha Cader provides her take on the ECLIPSE trial presented by Gregg W. Stone at ACC.25 in Chicago.

Author

Aaysha Cader
Impact of intravascular imaging guidance on percutaneous coronary intervention of severely calcified lesions: The ECLIPSE trial

PACMAN AMI: Effects of Alirocumab on Coronary Atherosclerosis Assessed by Serial Multimodality Intracoronary Imaging in Patients With Acute Myocardial Infarction

03 Apr 2022

Nicola Ryan provides a PICOT analysis of PACMAN AMI: a double-blind, placebo-controlled, randomized trial presented at ACC 2022 and simultaneously published in JAMA.

Nicola Ryan

Author

Nicola Ryan
PACMAN AMI: Effects of Alirocumab on Coronary Atherosclerosis Assessed by Serial Multimodality Intracoronary Imaging in Patients With Acute Myocardial Infarction: A Double-blind, Placebo-controlled, Randomized Trial

BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial

07 Nov 2022

Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.

This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...

Nicola Ryan

Author

Nicola Ryan
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial

Comparison of a precision care strategy with usual testing to guide management of stable patients with suspected CAD: the PRECISE randomized trial

09 Nov 2022

Alex Sticchi provides his take on PRECISE, which was presented during AHA 2022 in Chicago.

Alessandro Sticchi

Author

Alessandro Sticchi
Comparison of a precision care strategy with usual testing to guide management of stable patients with suspected coronary artery disease: the PRECISE randomized trial
Didn’t find what you were looking for?